Sony DADC to Develop Detection Vessels for Singulex's IVD Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Sony DADC Austria and Singulex today announced a supply agreement for the design and manufacture of customized detection vessels by Sony DADC BioSciences for Singulex's Sgx Clarity System.

Currently under development, Sgx Clarity is an ultrasensitive in vitro diagnostic platform that uses Singulex's proprietary single molecule counting technology. The fully automated system is expected to be able to detect low abundance biomarkers at femtograms per milliliter levels, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.